DK0819004T3 - Farmaceutisk sammensætning indeholdende protonpumpehæmmere - Google Patents
Farmaceutisk sammensætning indeholdende protonpumpehæmmereInfo
- Publication number
- DK0819004T3 DK0819004T3 DK96910664T DK96910664T DK0819004T3 DK 0819004 T3 DK0819004 T3 DK 0819004T3 DK 96910664 T DK96910664 T DK 96910664T DK 96910664 T DK96910664 T DK 96910664T DK 0819004 T3 DK0819004 T3 DK 0819004T3
- Authority
- DK
- Denmark
- Prior art keywords
- proton pump
- pharmaceutical composition
- composition containing
- pump inhibitors
- containing proton
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/416,275 US5708017A (en) | 1995-04-04 | 1995-04-04 | Stable, ready-to-use pharmaceutical paste composition containing proton pump inhibitors |
PCT/US1996/004355 WO1996031213A1 (en) | 1995-04-04 | 1996-03-29 | Pharmaceutical composition containing proton pump inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0819004T3 true DK0819004T3 (da) | 2009-11-30 |
Family
ID=23649308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96910664T DK0819004T3 (da) | 1995-04-04 | 1996-03-29 | Farmaceutisk sammensætning indeholdende protonpumpehæmmere |
Country Status (30)
Country | Link |
---|---|
US (1) | US5708017A (xx) |
EP (1) | EP0819004B1 (xx) |
JP (1) | JP4603631B2 (xx) |
KR (1) | KR100419105B1 (xx) |
CN (1) | CN1080119C (xx) |
AT (1) | ATE438380T1 (xx) |
AU (1) | AU703755B2 (xx) |
BR (1) | BR9604803A (xx) |
CA (1) | CA2217515C (xx) |
CY (1) | CY2613B2 (xx) |
CZ (1) | CZ287297B6 (xx) |
DE (1) | DE69637985D1 (xx) |
DK (1) | DK0819004T3 (xx) |
EA (1) | EA000087B1 (xx) |
EE (1) | EE03473B1 (xx) |
ES (1) | ES2329098T3 (xx) |
HK (1) | HK1004658A1 (xx) |
HU (1) | HU227864B1 (xx) |
IS (1) | IS2706B (xx) |
MX (1) | MX9707694A (xx) |
NO (1) | NO312994B1 (xx) |
NZ (1) | NZ305708A (xx) |
PL (1) | PL183144B1 (xx) |
PT (1) | PT819004E (xx) |
SI (1) | SI0819004T1 (xx) |
SK (1) | SK282872B6 (xx) |
TR (1) | TR199701117T1 (xx) |
UA (1) | UA42061C2 (xx) |
WO (1) | WO1996031213A1 (xx) |
ZA (1) | ZA962657B (xx) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173431B1 (da) * | 1998-03-20 | 2000-10-23 | Gea Farmaceutisk Fabrik As | Farmaceutisk formulering omfattende en 2-[[(2-pyridinyl)methyl]sulfinyl]benzimidazol med anti-ulcusaktivitet samt fremgangs |
WO1999053918A1 (fr) * | 1998-04-20 | 1999-10-28 | Eisai Co., Ltd. | Compositions stabilisees contenant des composes du type benzimidazole |
US6093734A (en) * | 1998-08-10 | 2000-07-25 | Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin | Prodrugs of proton pump inhibitors |
CN100396675C (zh) | 1998-08-10 | 2008-06-25 | 加利福尼亚州大学董事会 | 质子泵抑制剂的前药 |
GB2342292A (en) * | 1998-10-06 | 2000-04-12 | Mars Uk Ltd | Composition for the treatment of animal stereotypy comprises fat, fibre and optionally, a stomach antacid |
DE60009675T2 (de) * | 1999-02-23 | 2005-03-24 | Merck & Co., Inc. | Protonenpumpinhibitoren enthaltende zusammensetzung |
FR2793688B1 (fr) | 1999-05-21 | 2003-06-13 | Ethypharm Lab Prod Ethiques | Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques |
WO2001028559A1 (fr) | 1999-10-20 | 2001-04-26 | Eisai Co., Ltd. | Procede de stabilisation de composes benzimidazoles |
GB2358136A (en) * | 2000-01-15 | 2001-07-18 | Univ Montfort | A medicament for the treatment of equine oral stereotypies using a pH regulator |
US6787342B2 (en) * | 2000-02-16 | 2004-09-07 | Merial Limited | Paste formulations |
ATE473002T1 (de) * | 2000-05-30 | 2010-07-15 | Merial Ltd | Zusammensetzungen zur vorbeugung von geschwüren in pferden |
US6544556B1 (en) | 2000-09-11 | 2003-04-08 | Andrx Corporation | Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor |
US20020064555A1 (en) * | 2000-09-29 | 2002-05-30 | Dan Cullen | Proton pump inhibitor formulation |
WO2002032427A1 (en) * | 2000-10-20 | 2002-04-25 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
AU9163701A (en) * | 2000-10-27 | 2002-05-06 | Leo Pharma As | Topical composition containing at least one vitamin D or one vitamin D analogue and at least one corticosteroid |
US7357943B2 (en) * | 2000-12-07 | 2008-04-15 | Nycomed Gmbh | Pharmaceutical preparation in the form of a suspension comprising an acid-labile active ingredient |
PT1341524E (pt) * | 2000-12-07 | 2011-12-30 | Nycomed Gmbh | Preparação farmacêutica na forma de uma pasta compreendendo um ingrediente activo lábil a ácido |
US20050019390A1 (en) * | 2001-10-26 | 2005-01-27 | John Kohnke | Dosage system and dosage vehicle therefor |
AUPS244002A0 (en) * | 2002-05-20 | 2002-06-13 | John Kohnke Products Pty Ltd | Agent delivery system |
US20030228363A1 (en) * | 2002-06-07 | 2003-12-11 | Patel Mahendra R. | Stabilized pharmaceutical compositons containing benzimidazole compounds |
CA2490142A1 (en) * | 2002-07-03 | 2004-01-15 | Abbott Laboratories | Liquid dosage forms of proton pump inhibitors |
US6897227B2 (en) * | 2002-07-19 | 2005-05-24 | Winston Pharmaceuticals, Inc. | Prodrugs of proton pump inhibitors |
GB2394895A (en) * | 2002-11-06 | 2004-05-12 | Cipla Ltd | Proton pump inhibitor composition in paste form |
AU2004206141A1 (en) * | 2003-01-24 | 2004-08-05 | Niva Shapira | Synergistic compositions and methods for potentiating anti-oxidative activity |
WO2004112756A1 (en) * | 2003-06-26 | 2004-12-29 | Isa Odidi | Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient |
WO2005000269A1 (en) * | 2003-06-26 | 2005-01-06 | Cipla Limited | Pharmaceutical formulations comprising a proton pump inhibitor |
WO2005039640A1 (en) * | 2003-10-03 | 2005-05-06 | Allergan Inc. | Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs |
US20050075371A1 (en) * | 2003-10-03 | 2005-04-07 | Allergan, Inc. | Methods and compositions for the oral administration of prodrugs of proton pump inhibitors |
JP2007523163A (ja) * | 2004-02-18 | 2007-08-16 | アラーガン、インコーポレイテッド | プロトンポンプインヒビターのプロドラッグの投与のための方法および組成物 |
US20070161679A1 (en) * | 2004-02-18 | 2007-07-12 | Allergan, Inc. | Method and compositions for the intravenous administration of compounds related to proton pump inhibitors |
US20080287502A1 (en) * | 2004-03-30 | 2008-11-20 | Dermatrends, Inc. | Transdermal Administration of Proton Pump Inhibitors |
CA2561700A1 (en) * | 2004-04-16 | 2005-12-15 | Santarus, Inc. | Combination of proton pump inhibitor, buffering agent, and prokinetic agent |
US8394409B2 (en) * | 2004-07-01 | 2013-03-12 | Intellipharmaceutics Corp. | Controlled extended drug release technology |
US10624858B2 (en) | 2004-08-23 | 2020-04-21 | Intellipharmaceutics Corp | Controlled release composition using transition coating, and method of preparing same |
WO2006026829A1 (en) * | 2004-09-09 | 2006-03-16 | Metelli Pty Ltd | Stable paste composition of enteric coated acid labile active agent and use thereof |
US10064828B1 (en) | 2005-12-23 | 2018-09-04 | Intellipharmaceutics Corp. | Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems |
ES2609976T3 (es) * | 2006-01-27 | 2017-04-25 | Yale University | Combinación de sal de cinc y agente anti-H. pylori como inhibidor de acción rápida de la secreción de ácido gástrico |
US9561188B2 (en) * | 2006-04-03 | 2017-02-07 | Intellipharmaceutics Corporation | Controlled release delivery device comprising an organosol coat |
US10960077B2 (en) * | 2006-05-12 | 2021-03-30 | Intellipharmaceutics Corp. | Abuse and alcohol resistant drug composition |
AU2007266574A1 (en) * | 2006-06-01 | 2007-12-06 | Dexcel Pharma Technologies Ltd. | Multiple unit pharmaceutical formulation |
US20100317689A1 (en) * | 2006-09-19 | 2010-12-16 | Garst Michael E | Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety |
EP2486910A3 (en) | 2006-10-27 | 2012-08-22 | The Curators Of The University Of Missouri | Multi-chambered apparatus comprising a dispenser head |
US20080194307A1 (en) * | 2007-02-13 | 2008-08-14 | Jeff Sanger | Sports-based game of chance |
WO2008121887A1 (en) | 2007-03-30 | 2008-10-09 | Enterprises International, Inc. | Strapping track assembly and method of using the same |
EP2252274A4 (en) | 2008-02-20 | 2011-05-11 | Univ Missouri | COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME |
CN103550214A (zh) * | 2008-03-26 | 2014-02-05 | 塔罗制药北美有限公司 | 用于口服药剂的稳定脂质组合物 |
NZ591810A (en) | 2008-09-17 | 2012-12-21 | Chiasma Inc | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid |
DE102009018133A1 (de) * | 2009-04-15 | 2010-11-11 | Agon Pharma Gmbh | Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen |
GB201306720D0 (en) * | 2013-04-12 | 2013-05-29 | Special Products Ltd | Formulation |
US10238709B2 (en) | 2015-02-03 | 2019-03-26 | Chiasma, Inc. | Method of treating diseases |
EP3288556A4 (en) | 2015-04-29 | 2018-09-19 | Dexcel Pharma Technologies Ltd. | Orally disintegrating compositions |
US10076494B2 (en) | 2016-06-16 | 2018-09-18 | Dexcel Pharma Technologies Ltd. | Stable orally disintegrating pharmaceutical compositions |
AU2017310506B2 (en) | 2016-08-11 | 2019-11-21 | Dmk Pharmaceuticals Corporation | Drug compositions |
EP3299017A1 (en) * | 2016-09-23 | 2018-03-28 | The Boots Company PLC | Formulation |
CN107397719A (zh) * | 2017-08-16 | 2017-11-28 | 洛阳市兽药厂 | 一种畜禽用奥美拉唑可溶性粉剂及其制备工艺 |
US11564910B2 (en) | 2017-12-08 | 2023-01-31 | Adamis Pharmaceuticals Corporation | Drug compositions |
GB201804621D0 (en) * | 2018-03-22 | 2018-05-09 | Bcm Specials Ltd | Formulation |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
GB202116644D0 (en) | 2021-11-18 | 2022-01-05 | Innovate Pharmaceuticals Ltd | Liquid composition |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
IL75400A (en) * | 1984-06-16 | 1988-10-31 | Byk Gulden Lomberg Chem Fab | Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same |
JPS6150978A (ja) * | 1984-08-16 | 1986-03-13 | Takeda Chem Ind Ltd | ピリジン誘導体およびその製造法 |
AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
US5124158A (en) * | 1988-06-30 | 1992-06-23 | The Upjohn Company | Transdermal antisecretory agents for gastrointestinal disease |
JP2694361B2 (ja) * | 1989-02-09 | 1997-12-24 | アストラ アクチエボラグ | 抗菌剤 |
KR930000861B1 (ko) * | 1990-02-27 | 1993-02-08 | 한미약품공업 주식회사 | 오메프라졸 직장투여 조성물 |
SE9301489D0 (sv) * | 1993-04-30 | 1993-04-30 | Ab Astra | Veterinary composition |
KR0142815B1 (ko) * | 1994-12-02 | 1998-07-15 | 정도언 | 신규한 5-피롤릴-6-할로게노-2피리딜메틸설피닐벤즈이미다졸 유도체 |
GB2290965A (en) * | 1994-07-11 | 1996-01-17 | Therapicon Srl | Multiple layer capsules for drugs |
-
1995
- 1995-04-04 US US08/416,275 patent/US5708017A/en not_active Expired - Lifetime
-
1996
- 1996-03-29 NZ NZ305708A patent/NZ305708A/xx not_active IP Right Cessation
- 1996-03-29 EP EP96910664A patent/EP0819004B1/en not_active Expired - Lifetime
- 1996-03-29 MX MX9707694A patent/MX9707694A/es unknown
- 1996-03-29 JP JP53039196A patent/JP4603631B2/ja not_active Expired - Lifetime
- 1996-03-29 EE EE9700244A patent/EE03473B1/xx unknown
- 1996-03-29 WO PCT/US1996/004355 patent/WO1996031213A1/en active Search and Examination
- 1996-03-29 ES ES96910664T patent/ES2329098T3/es not_active Expired - Lifetime
- 1996-03-29 PT PT96910664T patent/PT819004E/pt unknown
- 1996-03-29 TR TR97/01117T patent/TR199701117T1/xx unknown
- 1996-03-29 EA EA199700294A patent/EA000087B1/ru not_active IP Right Cessation
- 1996-03-29 UA UA97115326A patent/UA42061C2/uk unknown
- 1996-03-29 CN CN96194084A patent/CN1080119C/zh not_active Expired - Lifetime
- 1996-03-29 PL PL96322619A patent/PL183144B1/pl unknown
- 1996-03-29 CA CA002217515A patent/CA2217515C/en not_active Expired - Lifetime
- 1996-03-29 KR KR1019970706980A patent/KR100419105B1/ko active IP Right Grant
- 1996-03-29 SK SK1350-97A patent/SK282872B6/sk not_active IP Right Cessation
- 1996-03-29 DE DE69637985T patent/DE69637985D1/de not_active Expired - Lifetime
- 1996-03-29 HU HU9801626A patent/HU227864B1/hu unknown
- 1996-03-29 DK DK96910664T patent/DK0819004T3/da active
- 1996-03-29 BR BR9604803A patent/BR9604803A/pt not_active Application Discontinuation
- 1996-03-29 AT AT96910664T patent/ATE438380T1/de active
- 1996-03-29 SI SI9630770T patent/SI0819004T1/sl unknown
- 1996-03-29 AU AU53797/96A patent/AU703755B2/en not_active Expired
- 1996-03-29 CZ CZ19973135A patent/CZ287297B6/cs not_active IP Right Cessation
- 1996-04-03 ZA ZA962657A patent/ZA962657B/xx unknown
-
1997
- 1997-10-02 IS IS4576A patent/IS2706B/is unknown
- 1997-10-03 NO NO19974589A patent/NO312994B1/no not_active IP Right Cessation
-
1998
- 1998-05-06 HK HK98103881.9A patent/HK1004658A1/xx not_active IP Right Cessation
-
2011
- 2011-01-04 CY CY1100001A patent/CY2613B2/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0819004T3 (da) | Farmaceutisk sammensætning indeholdende protonpumpehæmmere | |
BG105754A (en) | Pharmaceutical composition containing proton pump inhibitors | |
DK0696921T3 (da) | Veterinært præparat indeholdende en protonpumpeinhibitor | |
ATE218868T1 (de) | Hustenhemmende, theobromine enthaltende zusammensetzungen | |
DE69838647D1 (de) | Behandlung von fettleibigkeit | |
TNSN98049A1 (fr) | Composition pharmaceutique a residence gastrique. | |
CA2161683A1 (en) | Veterinary composition containing a proton pump inhibitor |